Intracerebral Hemorrhage in Aging: Pathophysiology, Clinical Challenges, and Future Directions

Esra Zhubi1, Andrea Lehoczki2,3, Peter Toth2,3,4,5

  • 1Department of Neurology, Semmelweis University, 1083 Budapest, Hungary.

Life (Basel, Switzerland)
|October 29, 2025
PubMed

Insights

Spontaneous intracerebral hemorrhage (ICH) and cerebral microbleeds (CMBs) are linked to aging, affecting older adults and contributing to cognitive decline. Understanding these aging-related mechanisms is key for developing new prevention and treatment strategies.

Area of Science:

  • Neurology
  • Gerontology
  • Vascular Biology

Background:

  • Spontaneous intracerebral hemorrhage (ICH) is a severe stroke type, common in older adults, leading to high mortality and cognitive impairment.
  • Aging impacts cerebral vasculature, increasing susceptibility to ICH and cerebral microbleeds (CMBs), which share underlying pathological mechanisms.
  • Cerebral microbleeds (CMBs) and ICH are part of a spectrum of hemorrhagic small vessel disease, contributing to vascular cognitive impairment and dementia (VCID).

Purpose of the Study:

  • To review the cellular, molecular, and systemic factors driving ICH and CMBs in aging.
  • To identify challenges in diagnosing and treating these conditions in older adults.
  • To outline strategies for age-sensitive prevention and personalized care.

Main Methods:

  • Literature review synthesizing current knowledge on aging-related ICH and CMBs.
  • Analysis of pathophysiological mechanisms including endothelial dysfunction, impaired autoregulation, and inflammation.
  • Examination of systemic factors like IGF-1 deficiency and their role in vascular vulnerability.

Main Results:

  • Aging alters cerebral vasculature, promoting ICH and CMBs through mechanisms like endothelial dysfunction, impaired autoregulation, and inflammation.
  • Age-related IGF-1 deficiency exacerbates microvascular vulnerability.
  • CMBs and ICH are interconnected on a disease continuum, contributing significantly to VCID.

Conclusions:

  • Older adults are underrepresented in clinical trials, necessitating age-specific research.
  • Current therapeutic approaches inadequately address aging-related mechanisms driving ICH and CMBs.
  • Developing individualized, age-sensitive strategies is crucial for preventing and managing these conditions.

Related Concept Videos

Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
580
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
183
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
511
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
223